Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glutathione S-transferase (GST) family members play an important role in detoxification, metabolism and carcinogenesis. The aim of this study is to investigate the effect of
Glutathione S-transferase A1
(
GSTA1
) on the prognosis of
HCC
and to understand its role in tumor progression and the possible mechanism.
GSTA1
in
HCC
was assessed using immunohistochemical staining, and it was found that
HCC
patients with better pathological differentiation had higher
GSTA1
abundance. Further, high
GSTA1
expression was correlated with low AFP, absent PVTT, and early stage TNM for
HCC
patients. Higher
GSTA1
indicated longer overall survival and disease-free survival, while lower
GSTA1
indicated poorer prognosis. Subsequently, lentiviral vector carrying
GSTA1
gene was successfully constructed and maintained high expression in 97H and SNU449 liver cancer cells. We found that high
GSTA1
restrained liver cancer cell proliferation, migration and invasion
in vitro
. Western blot showed that LKB1 and p-AMPK were upregulated while p-mTOR, p-p70 S6 Kinase and MMP-9 were downregulated in high
GSTA1
groups. Taken together, high
GSTA1
correlated with satisfactory prognosis of
HCC
. Additionally,
GSTA1
may act as a protective factor through suppression of tumorigenesis by targeting AMPK/mTOR in
HCC
.
...
PMID:Glutathione S-transferase A1 suppresses tumor progression and indicates better prognosis of human primary hepatocellular carcinoma. 3189 75